Lumos Diagnostics Holdings Ltd (asx:LDX) Share Price

Company Profile

Business description
Lumos Diagnostics Holdings Ltd is engaged in selling Products and providing Services to customers. Its product offering includes rapid, point-of-care diagnostic test products, mainly focused on the diagnosis and management of infectious diseases. Its product is FebriDx, a point-of-care test for detecting and differentiating viral and bacterial respiratory infections. Its Service offering includes contract research and development services specialising in innovation, development, manufacturing and commercialisation of point-of-care diagnostic test solutions. The Company has one operating segment, being the provision of point-of-care diagnostics goods and services. It operates in the United States and Australia, with the majority of revenue generated from the United States.
Contact
2724 Loker Avenue West
CarlsbadCA92010
USA
T: +1 855 586-6739
https://www.lumosdiagnostics.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
Employees

Recommended

We see regulatory risk from both the US and Chinese governments.

Seth Goldstein, CFA | 25 October 2026

Near-term pain, long-term potential.

Dan Baker | 22 October 2026

We see the company’s momentum in its core advertising business, as well as adoption of Muse, as early signals that the firm’s AI playbook is working.

Malik Ahmed Khan, CFA | 22 October 2026

Index	Last price	Change	% Change
All Ordinaries	8,926.60	20.80	0.23%
CAC 40	7,846.59	63.77	0.82%
DAX 40	25,399.56	217.91	0.87%
Dow JONES (US)	52,215.16	652.82	-1.23%
FTSE 100	10,737.68	47.32	0.44%
HKSE	23,211.81	118.44	0.51%
NASDAQ	25,955.34	53.52	-0.21%
Nikkei 225	62,189.65	503.51	-0.80%
NZX 50 Index	13,733.93	12.91	-0.09%
S&P 500	7,623.68	39.75	-0.52%
S&P/ASX 200	8,809.90	14.70	0.17%
SSE Composite Index	3,697.52	7.04	0.19%